Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
boston
5
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
5
×
rna interference
5
×
alnylam pharmaceuticals
clinical trials
san francisco blog main
biotech
fda
hereditary transthyretin amyloidosis
new york blog main
patisiran
san francisco top stories
akcea therapeutics
alexion pharmaceuticals
barry greene
boehringer ingelheim
craig mello
dan ollendorf
deals
hepatitis b
inotersen
new york top stories
san diego blog main
san diego top stories
tafamidis
vyndaqel
alnylam pharmaceutials
amy schulman
andreas klein
andrew fire
anna greka
arrowhead pharmaceuticals
boston university
car-t
caron jacobson
cigall kadoch
What
medicines
rna
ago
alnylam
dicerna
drug
fda
gene
gets
interference
medicine
pharma
pharmaceuticals
rnai
abandoning
afternoon
alnylam’s
approve
approved
aren’t
awaits
baggage
biological
car
caught
causing
companies
crossed
cuts
cutting
deal
decades
decision
development
discovered
disease
edge
experiments
eye
fingers
Language
unset
Current search:
photo
×
boston
×
" national top stories "
×
" rna interference "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”